A pediatric study of vibegron in participants with neurogenic detrusor overactivity

Recruiting Phase 2,Phase 3 NCT05491525

Study Description

Evaluating the safety and effectiveness of vibegron in children and adolescents with neurogenic bladder dysfunction

Study Details

Registry ID:
NCT05491525
Conditions:
Neurogenic Detrusor Overactivity
Phase:
Phase 2,Phase 3
Target Enrollment:
71 participants
Start Date:
Healthy Volunteers:
No

Study Locations (32 sites)

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →